These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 10673253)

  • 1. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
    Moss AJ; Zareba W; Hall WJ; Schwartz PJ; Crampton RS; Benhorin J; Vincent GM; Locati EH; Priori SG; Napolitano C; Medina A; Zhang L; Robinson JL; Timothy K; Towbin JA; Andrews ML
    Circulation; 2000 Feb; 101(6):616-23. PubMed ID: 10673253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
    Dorostkar PC; Eldar M; Belhassen B; Scheinman MM
    Circulation; 1999 Dec; 100(24):2431-6. PubMed ID: 10595956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
    Chatrath R; Bell CM; Ackerman MJ
    Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
    Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH
    PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.
    Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA
    J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome.
    Poterucha JT; Bos JM; Cannon BC; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1815-9. PubMed ID: 25929701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group.
    Rosero SZ; Zareba W; Moss AJ; Robinson JL; Hajj Ali RH; Locati EH; Benhorin J; Andrews ML
    Am J Cardiol; 1999 Dec; 84(12):1406-11. PubMed ID: 10606113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
    Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.
    Hobbs JB; Peterson DR; Moss AJ; McNitt S; Zareba W; Goldenberg I; Qi M; Robinson JL; Sauer AJ; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Towbin JA; Vincent GM; Zhang L
    JAMA; 2006 Sep; 296(10):1249-54. PubMed ID: 16968849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of death in the long QT syndrome when a sibling has died.
    Kaufman ES; McNitt S; Moss AJ; Zareba W; Robinson JL; Hall WJ; Ackerman MJ; Benhorin J; Locati ET; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    Heart Rhythm; 2008 Jun; 5(6):831-6. PubMed ID: 18534367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Peltenburg PJ; Kallas D; Bos JM; Lieve KVV; Franciosi S; Roston TM; Denjoy I; Sorensen KB; Ohno S; Roses-Noguer F; Aiba T; Maltret A; LaPage MJ; Atallah J; Giudicessi JR; Clur SB; Blom NA; Tanck M; Extramiana F; Kato K; Barc J; Borggrefe M; Behr ER; Sarquella-Brugada G; Tfelt-Hansen J; Zorio E; Swan H; Kammeraad JAE; Krahn AD; Davis A; Sacher F; Schwartz PJ; Roberts JD; Skinner JR; van den Berg MP; Kannankeril PJ; Drago F; Robyns T; Haugaa K; Tavacova T; Semsarian C; Till J; Probst V; Brugada R; Shimizu W; Horie M; Leenhardt A; Ackerman MJ; Sanatani S; van der Werf C; Wilde AAM
    Circulation; 2022 Feb; 145(5):333-344. PubMed ID: 34874747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.
    Toyota N; Miyazaki A; Sakaguchi H; Shimizu W; Ohuchi H
    Heart Vessels; 2015 Sep; 30(5):687-91. PubMed ID: 25028166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
    Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
    J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.
    Thottathil P; Acharya J; Moss AJ; Jons C; McNitt S; Goldenberg I; Zareba W; Kaufman E; Qi M; Robinson JL;
    Am J Cardiol; 2008 Oct; 102(7):871-4. PubMed ID: 18805113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in paediatrics.
    Kwok SY; Liu AP; Chan CY; Lun KS; Fung JL; Mak CC; Chung BH; Yung TC
    Hong Kong Med J; 2018 Dec; 24(6):561-570. PubMed ID: 30530868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.
    Theilade J; Kanters J; Henriksen FL; Gilså-Hansen M; Svendsen JH; Eschen O; Toft E; Reimers JI; Tybjærg-Hansen A; Christiansen M; Jensen HK; Bundgaard H
    Cardiology; 2013; 126(2):131-7. PubMed ID: 23969902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral contraceptives in women with congenital long QT syndrome.
    Goldenberg I; Younis A; Huang DT; Yoruk A; Rosero SZ; Cutter K; Kutyifa V; McNitt S; Sotoodehnia N; Kudenchuk PJ; Rea TD; Arking DE; Polonski B; Zareba W; Aktas MK
    Heart Rhythm; 2022 Jan; 19(1):41-48. PubMed ID: 34339849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
    Furushima H; Chinushi M; Washizuka T; Aizawa Y
    Jpn Circ J; 2001 Jul; 65(7):654-8. PubMed ID: 11446501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.